- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06946823
Implementation of a Just-In-Time Adaptive Intervention for Adolescent Anxiety
Community-Engaged Design and Implementation of a Just-In-Time Adaptive Intervention (JITAI) to Improve Adolescent Anxiety in Rural Populations
The goal of this clinical trial is to evaluate a smartphone based just-in-time adaptive intervention (JITAI) tool to deliver somatic behavioral recommendations for anxiety management among youth. The main questions it aims to answer are:
- Is the JITAI tool acceptable among the adolescent study population?
- Is the JITAI tool feasible to deliver to the adolescent study population?
- Does the study support preliminary efficacy of the JITAI tool among the adolescent study population?
The tool will be pilot-tested among a sample of 50 rural adolescents experiencing elevated anxiety levels who will be randomly assigned to the JITAI tool or a waitlist control, for a treatment period of 3 months.
Participants will be asked to:
- Use the smartphone based JITAI tool which will deliver somatic behavioral recommendations intended to manage anxiety levels for a treatment period of 3 months
- Respond to the tool's prompts on a daily basis and follow the delivered behavioral recommendations
- Complete anxiety and interoception assessments at study start, study end (3 months), and one-month follow-up
- Complete usability and user experience instruments at study end (3 months)
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Elizabeth Murnane, PhD
- Phone Number: 603-646-0775
- Email: emurnane@dartmouth.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adolescent (age 13-17 years old)
- New Hampshire resident
- Fluency in English
- Able to provide assent
- At least mild (≥5) anxiety based on the GAD-7 assessment
Exclusion Criteria:
- Under 13 years old
- Over 17 years old
- Not a New Hampshire resident
- Unable to provide assent
- Less than mild (<5) anxiety based on the GAD-7 assessment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Just-In-Time Adaptive Intervention for Adolescent Anxiety
Participants in the Just-In-Time Adaptive Intervention for Adolescent Anxiety Arm will receive the just-in-time adaptive smartphone tool and be instructed to respond to the tool's prompts and follow delivered behavioral recommendations throughout the 3-month intervention period.
|
A JITAI smartphone app to reduce anxiety levels among rural adolescents by delivering somatic-based activity recommendations
|
|
No Intervention: Waitlist Control
Participants in the Waitlist Control Arm will receive the just-in-time adaptive smartphone tool following the completion of the 3-month intervention period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in Symptoms of Generalized Anxiety at 3 Months
Time Frame: Baseline and 3 months
|
Units on a scale measured through the GAD-7 (Generalized Anxiety Disorder-7) self-report questionnaire.
Minimum score = 0, maximum score = 21, with a higher score indicating worse anxiety symptoms.
|
Baseline and 3 months
|
|
Change from Post-Treatment Symptoms of Generalized Anxiety to 1-month follow-up
Time Frame: Post-Treatment (3 months after baseline) and 1-month follow-up (4 months after baseline)
|
Units on a scale measured through the GAD-7 (Generalized Anxiety Disorder-7) self-report questionnaire.
Minimum score = 0, maximum score = 21, with a higher score indicating worse anxiety symptoms.
|
Post-Treatment (3 months after baseline) and 1-month follow-up (4 months after baseline)
|
|
Change from Baseline in Interoceptive Awareness at 3 Months
Time Frame: Baseline and 3 months
|
Units on a scale measured through the MAIA-Y (Multidimensional Assessment of Interoceptive Awareness for Youth) self-report questionnaire.
Minimum score = 1, maximum score = 5, with higher scores indicating greater interoceptive awareness.
|
Baseline and 3 months
|
|
Change from Post-Treatment Interoceptive Awareness to 1-month follow-up
Time Frame: Post-Treatment (3 months after baseline) and 1-month follow-up (4 months after baseline)
|
Units on a scale measured through the MAIA-Y (Multidimensional Assessment of Interoceptive Awareness for Youth) self-report questionnaire.
Minimum score = 1, maximum score = 5, with higher scores indicating greater interoceptive awareness.
|
Post-Treatment (3 months after baseline) and 1-month follow-up (4 months after baseline)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pragmatic and Hedonic User Experience
Time Frame: 3 months after baseline
|
The AttrakDiff instrument assesses 4 dimensions of user experience (usability, stimulation, identity, and attractiveness) using a 7-point semantic differential scale where respondents choose between bipolar adjective pairs to produce an overall mean score.
Minimum score = -3, maximum score = +3, where higher scores indicate a more usable and appealing tool.
|
3 months after baseline
|
|
Technology Engagement
Time Frame: 3 months after baseline
|
The GiggleGauge instrument assesses user engagement through a self-report questionnaire with a binary ordinal scale.
Minimum score = 5, maximum score = 10, where higher scores indicate a more engaging tool.
|
3 months after baseline
|
|
User Engagement
Time Frame: 3 months after baseline
|
The User Engagement Scale (UES) instrument assesses user engagement with digital interventions through a self-report questionnaire on a 5-point Likert scale.
Minimum score = 1, maximum score = 5, where higher scores indicate a more engaging tool.
|
3 months after baseline
|
|
Percentage of app-based intervention activities completed by participants
Time Frame: Baseline through 3-month treatment period
|
Compliance will be assessed by calculating the percentage of assigned app-based intervention activities completed by each participant over the 3-month treatment period.
Completion data will be automatically recorded by the app.
|
Baseline through 3-month treatment period
|
|
Number of participants who complete the study
Time Frame: End of treatment period (3 months after baseline)
|
Retention will be defined as the number of participants who remain enrolled and complete all study procedures through the end of the treatment period at 3 months.
|
End of treatment period (3 months after baseline)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00033184
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety Disorders
-
University of CalabriaNot yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking AnxietyItaly
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiActive, not recruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Abant Izzet Baysal UniversityRecruitingAnxiety | Parental AnxietyTurkey (Türkiye)
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston University; Johns Hopkins... and other collaboratorsCompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety DisordersUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
University of Colorado, BoulderEnrolling by invitationStress | Anxiety | Social AnxietyUnited States
-
Institut National de la Santé Et de la Recherche...Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and FearFrance
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
Clinical Trials on Just-In-Time Adaptive Intervention for Adolescent Anxiety
-
Wageningen University and ResearchZonMw: The Netherlands Organisation for Health Research and DevelopmentCompleted
-
University of Alabama, TuscaloosaUniversity of Alabama at BirminghamUnknownCancer | Aging | Comorbidities and Coexisting Conditions
-
University of MichiganNational Institute on Drug Abuse (NIDA)Completed
-
University of ZurichRecruitingDepressive Symptoms | Loneliness | Social SupportSwitzerland
-
University of MichiganNational Institute of Nursing Research (NINR)CompletedCaregiversUnited States
-
University of MichiganNational Center for Advancing Translational Sciences (NCATS)CompletedCaregiversUnited States
-
Colliga Apps Corp.National Institute of Mental Health (NIMH)CompletedFamily Functioning | Mental Health and Well-beingUnited States
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | Blood PressureUnited States
-
Kaiser PermanenteNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Washington University School of MedicineNational Institute of Mental Health (NIMH); Duke University; WysaRecruitingChronic Pain | Depression, AnxietyUnited States